Optinose Inc. (OPTN)

Trade OPTN now with
6/6/2018 8:57:44 PM OptiNose Announces Pricing Of Underwritten Public Offering Of 5 Mln Shares At $22.25/shr
5/14/2018 7:10:06 AM Optinose Q1 Loss Attributable To Common Stockholders $30.6 Mln Or $0.81/Shr Vs Loss $11.7 Mln Or $2.87/Shr Last Year
3/13/2018 7:13:19 AM Optinose Q4 Loss Per Share $0.64 Vs Loss $2.18 Last Year
12/11/2017 8:17:38 AM Minerva Neurosciences Elects William Doyle And Hans Peter Hasler To Board
11/27/2017 4:09:29 PM Optinose Q3 Loss/share $4.23 Vs. Loss $2.32 Year Ago
11/7/2017 7:27:29 AM RBC Capital Markets Initiates OptiNose Inc. (OPTN) At Outperform With $33.0 Price Target